📰 Life Sciences Plc News
Page 3 - Life Sciences Plc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Life Sciences Plc. Real-time updates on events, politics, business and more.
January 18, 2021
Directorate Changes RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the worlds leading long-term implantable biostable polymer (Elast-Eon TM), is pleased to announce the appointments, with immediate effect, to the Board of Dr Caroline Stretton, Group Chief Operating Officer of the Company, and Ian Ardill as a Non-Executive Director and Chair of the Audit Committee. Dr Caroline Stretton who was appointed as...
December 30, 2020
RUA Life Sciences plc (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Furthermore, as announced earlier today the Open Offer closed for acceptances at 11.00 a.m. on 29 December 2020 with final valid applications from Qualifyi...
December 11, 2020
Open Offer to Qualifying Shareholders to raise up to a further £1.0m Cenkos Securities plc appointed joint broker RUA Life Sciences plc (AIM: RUA or the "Company" or the "Group"), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer, is pleased to announce it has conditionally raised approximately £6.0 million by way of a Placing and Subscription to new and existing investors. Furthermore...
December 11, 2020
Unaudited Interim Results RUA Life Sciences plc (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer , announces its unaudited interim results for the six months ended 30 September 2020. Highlights · Products on schedule for regulatory submission in 2021 · Positive testing on polymeric heart valve · The...
December 11, 2020
Directorate Change RUA Life Sciences plc (AIM:RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer, announces that Gordon Wright has resigned as a non-executive Director of the Company with effect from 10 December 2020. As previously reported in the Companys audited results for the year ended 31 March 2020, Gordon, who was the founder of the predecessor AorTech...